A growing and glowing story: Scientex Berhad
“Growth is never by mere chance; it is the result of forces working together.”
Few retail investors are interested in Scientex Berhad. The share price hardly moves (in the short term), there ain’t no excitement. Why bother about it?
Historical Share Price movement
Figure 1a below shows the steady increase in share price of Scientex (SCI) from 2000 to 2014. It has risen from an adjusted price of less than 62 sen 14 years ago to the close of RM5.74 on 21st July 2014, 8.3 times increase in price, or a compounded growth rate (CAGR) of 16.7% a year. This compares to 104% or a CAGR of just 5% for the broad KLCI during the same period. The steep rise of share price of SCI was actually from March 2009 when it recovered from the US sublime housing crisis when the share price rose from 85.5 sen to RM5.74 now for a total rise of 580%, or a CAGR of 43.5%, compared to 116%, or a CAGR of 15.6% for KLCI. The extra-ordinary return of SCI over the broad index is truly extraordinary.
Figure 1a: Scientex historical share price movement
Corporate background
Established in 1968, SCI was previously involved in the production of polyvinyl chloride leather cloth as well as sheeting for industrial and consumer products. SCI diversified into property development in 1995, with its existing projects now predominantly centered in Johor and Melaka. SCI’s property development division is currently sitting on an undeveloped land bank of 990 acres with a total remaining GDV of MYR4.4bn to be developed over the next 10 years.
After the takeover of GW Plastic Bhd end of 2012 and the acquisition of Seacera Polymer Sdn Berhad early this year, SCI became one of the world’s leading industrial packaging manufacturers with various products such as stretch film, laminated bags, bulk bags, corrugated carton boxes etc. It is now the third largest stretch film manufacturer in the world and the largest in Asia with about 33% market share. Its annual production capacity of flexible stretch film reaches 194,000 tonnes per year. The group manufactures resin-based film for the logistics, food & beverage (F&B) and fast-moving consumer goods (FMCG) segments. Its products are being exported to over 60 countries around the world.
The group’s manufacturing division contributed 79% of its topline and 54% of consolidated EBITDA in 1QFY14, while the remainder was from its property division. SCI’s growth will be driven further by the expansion of its manufacturing production lines as well as sustainable growth in its property development in the coming years. Figure 1 below shows the corporate structure of SCI.
The quality growth story
Figure 2 below shows the unabated growth, except with a little kink during the US sublime crisis in 2009, of SCI from RM250 million sales in 2003 to the Billion Ringgit Club of RM1.23 billion in 2013, a CAGR of 17.3% for the last 10 years.
I normally am not too excited about this type of high revenue growth story unless it is accompanied with corresponding earnings growth. SCI does satisfy this quality growth as shown in Figure 3 below.
Earnings grew in tandem with sales from RM7.0m in 2003 to RM112.5m in 2013, or a CAGR of 32% for the last 10 years. More importantly, the earnings growth is accompanied with continuous growth in cash flows. Figure 3 shows that cash flows from operations have been consistently more than net profits, signifying the excellent quality of earnings and its growth.
The great story is replayed in its balance sheets with its growth in equity as shown Figure 4 below.
The common shareholder equity grows by 8% and 13% for the last ten and five years respectively. This is despite SCI having been giving good dividends all these years. Just how has SCI been funding this high growth?
Return of Equity (ROE)
The ROE of SCI improves by leaps and bounds from less than 2% ten years ago, surpassing 10% in two years later in 2005, and surging to 17.5% in 2013. The high ROE provided surplus funds from its ordinary business to be invested to improve business operations without the shareholders having to invest more capital. It also means that there is less need to borrow. That is exactly what SCI is able to achieve as shown in Figure 5 below.
How is the efficiency of SCI compared to its peers? The picture in Figure 6 below paints a thousand words. It shows the comparison among some flexible plastic packaging companies with SCI.
It is evidence that SCI is the best among its peers in terms of operational efficiencies.
I always say that a good company is not necessary a good investment if the price is not right. Let us examine the market valuation of SCI compared to some of its peers.
Some Simple Valuations
At the close of RM5.74 on 18th July, 2014, SCI is trading at a price 11.6 times its 2013 earnings and 2.1 times its book value, 6.2 times its cash flows and 8.4 times free cash flow as shown in Table 1 below. Its enterprise value is 1.3 times its sales. Earnings yield at just 9.4% appears to be slightly pricey.
Table 1: Comparisons of valuations of SCI with its peers
Company |
Scientex |
Daibochi |
Tomypak |
Thong Guan |
BP Plastic |
Price on 18/7/14 |
5.74 |
4.40 |
1.38 |
2.43 |
0.83 |
Price/Earnings |
11.7 |
18.0 |
10.6 |
8.9 |
14.7 |
Price/Book |
2.1 |
3.1 |
1.4 |
0.9 |
1.0 |
Price/CFFO |
6.2 |
17.3 |
6.1 |
13.2 |
9.6 |
Price/FCF |
8.4 |
NA |
14.3 |
102.5 |
11.9 |
EV/Sales |
1.3 |
1.7 |
0.7 |
0.3 |
0.4 |
Earnings yield EBIT/EV |
9.4% |
6.7% |
12.5% |
11.7% |
11.4% |
Comparing with another leader in flexible plastic packaging company Daibochi with slightly lower efficiencies, despite SCI being four times the size of Daibochi in revenue, Scientex is trading much cheaper in every aspect. For example, PE and P/B ratio at 11.8 and 2.1 is 30% cheaper than those of Daibochi. Earnings yield wise, it is 40% cheaper. Its price to cash flows and sales are also much cheaper.
Compared with Thong Guan, Scientex PE ratio is higher by 30% and earnings yield lower by 20% and hence appears to be pricier. However, SCI’s ROE is 80% higher and its price-to-CFFO is 50% lower
Scientex price to cash flows are also cheaper than all other companies. Its price to earnings and book value are generally higher though compared with other companies.
Discount cash flow analysis
Using the following data and assumptions, the discount cash flow analysis shows that the intrinsic value of SCI is RM8.51. This represents a margin of safety of 33% investing in SCI at RM5.74.
Data and assumptions
Average Free Cash Flow for firm the last 5 years RM93.3m
Growth in FCF, next 5 years 12%, 7% subsequent 5 years and a terminal growth of 3% after.
Discount rate 10% as its earnings and cash flow are stable and with high earnings visibility.
The results are shown below:
PV of FCFF |
$2,271,000 |
Excess cash |
$59,969 |
Debts |
($335,437) |
PV of FCFE |
$1,995,532 |
MI |
($39,255) |
$1,956,277 |
|
Number of shares |
230000 |
FCF per share |
$8.51 |
MOS |
33% |
Scientex third quarter 2014 results
SCI announced its third quarterly 2014 result ended 30th April 2014 on 19th June 2014. For the nine months period, revenue increased by 37% to 1.175b while net profit increased by 27% to 101.7m, or 45 sen per share. The growth story appears to be well alive.
Catalyst?
With such a convincing growth story, do you really need a catalyst for its share price to go up? Think about it, may be a corporate exercise such as a 1 for 1 bonus will be good as SCI has heaps of retained earnings of 5 times its share capital to do that. Another possible corporate exercise is the spinning off its highly profitable property development arm to unlock its true value.
Conclusions
SCI has a long history of glowing growing story, thanks to its dynamic management with the same interest alignment with the shareholders. More importantly there is clear visibility of its high future earnings growth too. It has growing high efficiencies which provide it with internally generated capital for future growth. It is the biggest among its peers in Bursa and hence a good marketing network, pricing power and cost advantages over its peers for sure. I particularly like its abundance in cash flows. However, taking everything into consideration, its market valuation is inexpensive, and in fact much lower than Daibochi, its nearest investing rival in every aspects. The margin of safety of 30% provides adequate safety net investing in this stock.
Does this mean that we can have our cake and eat it too by investing in SCI at RM5.74?
K C Chong on 21st July 2014.
Chart | Stock Name | Last | Change | Volume |
---|
2024-11-24
SCIENTX2024-11-19
SCIENTX2024-11-18
SCIENTX2024-11-14
SCIENTX2024-11-14
SCIENTX2024-11-14
SCIENTX2024-11-14
SCIENTX2024-11-13
SCIENTX2024-11-13
SCIENTX2024-11-13
SCIENTX2024-11-13
SCIENTX2024-11-13
SCIENTX2024-11-13
SCIENTX2024-11-13
SCIENTX2024-11-13
SCIENTX2024-11-13
SCIENTXCreated by kcchongnz | Jan 22, 2024
Which to buy, Insas or Insas WC?
Created by kcchongnz | Jan 15, 2024
Created by kcchongnz | Jan 01, 2024
Created by kcchongnz | Dec 25, 2023
Created by kcchongnz | Oct 02, 2022
As usual, a good company recommended.
I would think the property division is posing a drag on valuation and would look forward for corporate exercise as the company valuation should be in line with peers if not premium.
2014-07-22 08:21
Current Valuation might also be Sum of Part valuation whereby manufacturing is valued higher than the property division.
2014-07-22 10:42
Well timing of spin off must be considered as well to maximize the value.
Anyway, a very capable management team.
2014-07-22 12:44
A clear leader in its own industry. Same as Pintaras. Same as CBIP. Same as Padini etc.
I would say all these leaders will be doing very well in the next decades.
2014-07-23 15:33
Scientex, a stock i overlooked, a co that once hired me in dec 1999. Wow,the growth really continue,saw it star last 2wks.
Abt Graham method, there's a way to achieve abt 20% pa using graham-dodd method. But it's very very boring and u can only buy/sell once every few yrs. but good la,less hassle/work
2014-08-05 05:37
buying and keep stock on closing market to realise its hidden potentials , Some quoted its intrinsive value at around RM 8.51...now is trading less than RM 6.00, so it is a real bargain at present price . Even top management has hinted its earning per share may breach RM 1.00 for 4th qtr this year ...if this happens , what will be the price after this ?
2014-08-08 17:18
Nice result for FY14. Read this article earlier, but I do not take action. How I wish I could react immediately after reading kcchongnz article. :(
2014-09-25 08:58
AyamTua
Abang: $5.74 bit mahal lah for layman like me.. wishing that someday, there's some blog below $1.00 for the layman like me with limited amount of cash to invest in .. love your coverage on FIBON, WILOW, HEXZA, NTPM, HOMERIZ, etc etc like last time ............. but ofcourse ada duit I will go for all what you recommended more than $1.00 .... thanks for the post.. I read and good points there....
2014-07-21 22:07